Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127703021 | 12770302 | 1 | I | 20150918 | 20160922 | 20160922 | PER | US-DRREDDYS-USA/USA/15/0052834 | DR REDDYS | 52.00 | YR | F | Y | 0.00000 | 20160922 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127703021 | 12770302 | 1 | PS | FLUCONAZOLE. | FLUCONAZOLE | 1 | Oral | Y | U | C500517 | 76658 | 150 | MG | TABLET | QD | ||||
| 127703021 | 12770302 | 2 | C | INVOKANA | CANAGLIFLOZIN | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127703021 | 12770302 | 1 | Vulvovaginal mycotic infection |
| 127703021 | 12770302 | 2 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127703021 | 12770302 | Bronchitis | |
| 127703021 | 12770302 | Dyspnoea | |
| 127703021 | 12770302 | Ocular hyperaemia | |
| 127703021 | 12770302 | Product quality issue | |
| 127703021 | 12770302 | Sputum discoloured |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |